AMAnne-Geneviève MarcelinMDSlidesetHIVEuropean HIV Clinical Forum 2017What is the virological support for reduced drug regimens?- Anne-Geneviève Marcelin, MDView Slideset
CBCharles BoucherMD, PhDSlidesetHIVEuropean HIV Clinical Forum 2017State of the ART: Integrase Inhibitors Resistance- Charles Boucher, MD, PhDView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Effect of high-risk sexual behaviouron diversity of the vaginal microbiota and abundance of lactobacillus- Jocelyn WesselsView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Modulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques- Zhang WangView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Vaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition- Gilda TachedjianView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Cervicovaginal microbial dynamics and its impact on HIV acquisition risk- Douglas Kwon, MD, PhDView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Plasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis- Qibin Qi, PhDView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Microbial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques- Alexandra OrtizView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Microbial colonization of the gut and brain development in infancy- Rebecca Knickmeyer, PhDView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Role of the microbiome in HIV vaccine response heterogeneity- James Kublin, MD, MPHView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017Opening Lecture: Brain-Gut-Microbiota interactions and intestinal health- Wendy Henderson, PhD, MSN, CRNPView Slideset
SlidesetHIVInternational Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2017The microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation- Jon KibbieView Slideset
